Back to search

Article

Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer

2026-07-01

Abstract excerpt

<title>Abstract</title> <p> BACKGROUND Survival outcomes following sipuleucel-T in men with metastatic androgen pathway modulator resistant prostate cancer (mAPMR) are variable. Genomic alterations influencing immune response and tumor proliferation may explain outcome heterogeneity. We sought to identify clinical and genomic correlates of survival following sipuleucel-T. METHODS We conducted a single-center r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf7ce73d-89a7-5817-bb25-5be717a15e4f
DOI
10.21203/rs.3.rs-10042173/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancerDOI 10.21203/rs.3.rs-10042173/v1
Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate CancerSemantic proximity
Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic FrontiersSemantic proximity
Oncogenic Alterations, Race, and Survival in US Veterans with Metastatic Prostate Cancer Undergoing Somatic Tumor Next Generation SequencingSemantic proximity
Prognostic Significance of Circulating Tumor DNA in Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis.Semantic proximity
Differential Response to 177Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.Semantic proximity
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerSemantic proximity
Integration of genomic classification and clinical characteristics predicts survival in metastatic prostate cancerSemantic proximity
Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized TherapySemantic proximity
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerSemantic proximity
Integrating Aggressive Variant Prostate Cancer-Associated Tumor Suppressor Gene Status to Refine Prognosis and Predict Androgen-Receptor Pathway Inhibitors Response in Metastatic Hormone-Sensitive Prostate CancerSemantic proximity
Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancerSemantic proximity
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trialSemantic proximity
Select a neighboring publication to make it the new centre.